Khiron Life Sciences Modifies Agreement for Sale of European Subsidiaries - Kalkine Media

November 19, 2023 12:00 AM EST | By Team Kalkine Media
Follow us on Google News:

Khiron Life Sciences Corp. (TSXV: KHRN), a key player in TSX healthcare stocks, has recently made substantial modifications to its share purchase agreement with 2518542 Alberta Ltd., focusing on the sale of Khiron’s European subsidiaries. According to the revised agreement, the purchaser is set to acquire the European subsidiaries for a total purchase price of $3 million. Notably, the option agreement that would have facilitated the purchaser's acquisition of all shares of Khiron’s Colombian subsidiary, Zerenia S.A.S, has been removed from the deal. This adjustment was made in response to the conditions outlined by the TSX Venture Exchange (TSXV) for approving the transaction.

TSXV KHRN has successfully obtained conditional approval for the transaction from the TSXV and has secured the necessary approvals under the German Foreign Trade and Payments Act and Regulation. These approvals specifically pertain to the sale and purchase of the outstanding shares of Pharmadrug Production GmbH. The completion of the sale and purchase of Pharmadrug’s shares, coupled with the transfer of all shares of Khiron Europe GmbH and Zerenia Clini, is anticipated to occur around November 17, 2023.

The amended agreement underscores Khiron’s commitment to meeting regulatory requirements and efficiently finalizing the sale of its European subsidiaries. This move exemplifies the company’s dedication to executing strategic business transactions while ensuring compliance with exchange regulations.


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Top TSX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK